Andra AP fonden Boosts Holdings in HCA Healthcare, Inc. $HCA

Andra AP fonden boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 21.1% during the 2nd quarter, Holdings Channel.com reports. The firm owned 56,323 shares of the company’s stock after purchasing an additional 9,800 shares during the period. Andra AP fonden’s holdings in HCA Healthcare were worth $21,960,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in HCA Healthcare during the second quarter worth about $5,069,974,000. Capital World Investors boosted its holdings in HCA Healthcare by 0.8% in the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after buying an additional 40,086 shares during the period. Wellington Management Group LLP raised its holdings in HCA Healthcare by 20.5% during the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after acquiring an additional 799,761 shares during the period. Geode Capital Management LLC boosted its holdings in shares of HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after acquiring an additional 13,565 shares during the period. Finally, Norges Bank bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,262,513,000. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Cantor Fitzgerald lowered their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a report on Tuesday, July 7th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $435.00 price objective on shares of HCA Healthcare in a report on Tuesday, September 8th. Barclays cut their price objective on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a report on Monday, July 27th. Morgan Stanley cut their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research note on Monday, July 27th. Finally, Oppenheimer lowered their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $462.27.

HCA Healthcare Stock Performance

HCA traded up $10.98 on Tuesday, hitting $436.95. 427,839 shares of the company were exchanged, compared to its average volume of 1,358,292. The stock has a market capitalization of $94.60 billion, a PE ratio of 14.63, a price-to-earnings-growth ratio of 1.44 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The firm has a fifty day simple moving average of $407.15 and a two-hundred day simple moving average of $428.24.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the business earned $6.84 earnings per share. On average, equities analysts expect that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.45%.

HCA Healthcare Profile

HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.